Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer D Goldman

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The American Journal of Managed Care|August 31, 2018
Antihyperglycemic medications for cardiovascular disease risk reductionJennifer D Goldman
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2023
DeniabetesJennifer D Goldman
Journal of Clinical Pharmacy and Therapeutics|September 10, 2020
Cardiovascular safety outcomes of once-weekly GLP-1 receptor agonists in people with type 2 diabetesJennifer D Goldman
Clinical Medicine Insights. Endocrinology and Diabetes|July 18, 2018
Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes TherapyJennifer D Goldman
Journal of Pharmacy Practice|May 28, 2024
Optimizing Finerenone in People With Diabetes and Chronic Kidney Disease: An Opportunity for the PharmacistJennifer D Goldman
The Annals of Pharmacotherapy|March 15, 2015
Combination therapy when metformin is not an option for type 2 diabetesJennifer D Goldman-Levine
Pharmacotherapy|November 30, 2011
Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitusJennifer D Goldman-Levine
Clinical Diabetes : a Publication of the American Diabetes Association|May 2, 2024
Donislecel: First Cellular Therapy to Treat Patients With Brittle Type 1 DiabetesOjashwi Giri, Jennifer D Goldman
Clinical Diabetes : a Publication of the American Diabetes Association|January 20, 2025
High-Concentration Capsaicin Topical System for Painful Diabetic Peripheral NeuropathyHailey Choi, Jennifer D Goldman
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2023
Teplizumab: The First Treatment to Delay the Progression of Type 1 DiabetesJennifer D Goldman, Hailey Choi
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The American Journal of Managed Care|August 31, 2018
Antihyperglycemic medications for cardiovascular disease risk reductionJennifer D Goldman
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2023
DeniabetesJennifer D Goldman
Journal of Clinical Pharmacy and Therapeutics|September 10, 2020
Cardiovascular safety outcomes of once-weekly GLP-1 receptor agonists in people with type 2 diabetesJennifer D Goldman
Clinical Medicine Insights. Endocrinology and Diabetes|July 18, 2018
Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes TherapyJennifer D Goldman
Journal of Pharmacy Practice|May 28, 2024
Optimizing Finerenone in People With Diabetes and Chronic Kidney Disease: An Opportunity for the PharmacistJennifer D Goldman
The Annals of Pharmacotherapy|March 15, 2015
Combination therapy when metformin is not an option for type 2 diabetesJennifer D Goldman-Levine
Pharmacotherapy|November 30, 2011
Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitusJennifer D Goldman-Levine
Clinical Diabetes : a Publication of the American Diabetes Association|May 2, 2024
Donislecel: First Cellular Therapy to Treat Patients With Brittle Type 1 DiabetesOjashwi Giri, Jennifer D Goldman
Clinical Diabetes : a Publication of the American Diabetes Association|January 20, 2025
High-Concentration Capsaicin Topical System for Painful Diabetic Peripheral NeuropathyHailey Choi, Jennifer D Goldman
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2023
Teplizumab: The First Treatment to Delay the Progression of Type 1 DiabetesJennifer D Goldman, Hailey Choi
Pageof 4